• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gen Virol. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza A/H5N1 and immunodomi

Giuseppe

Emeritus
Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza A/H5N1 and immunodominance of virus specific CD8+ T cell responses in mice. (J Gen Virol., abstract, edited)

[Source: US National Library of Medicine, (LINK). Edited.]

J Gen Virol. 2010 Mar 24. [Epub ahead of print]

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza A/H5N1 and immunodominance of virus specific CD8+ T cell responses in mice.

Bodewes R, Kreijtz JH, Hillaire M, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. - Department of Virology, Erasmus Medical Center.

Recently we have demonstrated that the use of an experimental subunit vaccine protected mice against infection with a human A/H3N2 influenza virus, but consequently affected the induction of heterosubtypic immunity to a highly pathogenic A/H5N1 influenza virus, otherwise induced by the A/H3N2 infection. Since inactivated whole virus (WIV) vaccines are widely used to protect against seasonal influenza and also contain inner viral proteins like the nucleoprotein, we tested the potential of a WIV vaccine to induce protective immunity against infection with a homologous A/H3N2 (A/Hong Kong/2/68) and a heterosubtypic A/H5N1 influenza virus (A/Indonesia/5/05). As expected, the vaccine afforded protection against infection with the A/H3N2 virus only. In addition, we demonstrated that the use of WIV vaccine for the protection against A/H3N2 infection affected the induction of heterosubtypic immunity otherwise afforded by A/H3N2 influenza virus infection. The reduction of protective immunity correlated with changes in the immunodominance patterns of the CD8+ T cell responses directed to the epitopes located in the acid polymerase (PA224-233) and the nucleoprotein (NP366-374). In unvaccinated mice that experienced an infection with the A/H3N2 influenza virus, the magnitude of the CD8+ T cell response to both peptides was similar upon a secondary infection with an A/H5N1 influenza virus. In contrast, prior vaccination with WIV affected the immunodominance pattern and skewed the response after infection with influenza virus A/Indonesia/5/05 towards a dominant NP366-374 specific response. These findings may have implications for vaccination strategies aiming at the induction of protective immunity to seasonal and/or pandemic influenza.

PMID: 20335492 [PubMed - as supplied by publisher]
-
------
 
Back
Top Bottom